And NWBO stands to be their biggest client once Direct is approved for all solid tumors, as well as other therapies that result from DC's. It is in her interest overwhelmingly to get first L, then Direct cranked out at Advent.
I believe it is around 180m warrants, options and shares (could be wrong, going off of memory here). Your prediction seems a little "modest". I'd call her stake enormous.
She also owns an unknown percent of Advent. Many would guess it is far more than the stake in NWBO.
So, you don't know what she owns. You don't know the value of Advent. CDMO's are typically worth far less than their clients. Yet, without any details provided you make the statement that LP's Advent interest are worth more than her NWBO interest. Sounds like bullshit.
There is a reason everything they do is to establish Advent as CDMO.
Sure, if you ignore the PRs, the recent lawsuit language or the ASM that all talk about the work with consultants to prepare multiple filings for RA approval(s).